For the year ending 2025-12-31, RANI made $1,633K in revenue. -$29,673K in net income. Net profit margin of -1817.09%.
| Income Statement | 2025-12-31 | 2024-12-31 | ||
|---|---|---|---|---|
| Contract revenue | 1,633 | 1,028 | ||
| Research and development | 20,205 | 26,682 | ||
| General and administrative | 19,738 | 23,946 | ||
| Impairment loss | 0 | 3,714 | ||
| Total operating expenses | 39,943 | 54,342 | ||
| Loss from operations | -38,310 | -53,314 | ||
| Interest income and other, net | 827 | 1,763 | ||
| Interest expense and other, net | 2,891 | 5,033 | ||
| Loss on extinguishment of debt | -576 | - | ||
| Net loss | -40,950 | -56,584 | ||
| Net loss attributable to non-controlling interest | -11,277 | -26,566 | ||
| Net loss attributable to rani therapeutics holdings, inc | -29,673 | -30,018 | ||
| Basic EPS | -0.45 | -1.05 | ||
| Diluted EPS | -0.45 | -1.05 | ||
| Basic Average Shares | 66,138 | 28,476 | ||
| Diluted Average Shares | 66,138 | 28,476 | ||
Rani Therapeutics Holdings, Inc. (RANI)
Rani Therapeutics Holdings, Inc. (RANI)